Click here to read more Quest articles. print | Print this page
From the Summer/Fall 2019 Quest
Research continues to explore if the antiinflammatory effects of aspirin could benefit men after they are diagnosed with prostate cancer.

Arecent large study from Denmark sought to determine if men who regularly took aspirin after being diagnosed with prostate cancer had a lower risk of dying from the disease. While the study did not find an overall link between aspirin use and prostate cancer mortality rates, the research suggested a possible benefit for men five years after a diagnosis.

Earlier research on this topic has been inconclusive. QUEST previously reported on a study in 2017 that found a beneficial relationship between regular aspirin use and prostate cancer. Further research is needed to assess the impact of aspirin on prostate cancer.

Ann Intern Med. 2019 Mar 5. doi: 10.7326/M17-3085.



Close this window